143 related articles for article (PubMed ID: 6131828)
1. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
Engel B; Einstein R; Goodman AH
Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
[TBL] [Abstract][Full Text] [Related]
2. Inotropic selectivity of salbutamol and terbutaline in anaesthetised, areflexic dogs.
Engel B; Einstein R; Goodman AH
Eur J Pharmacol; 1985 Oct; 116(1-2):97-104. PubMed ID: 4054218
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the cardiac effects of beta-adrenoreceptor agonists in anaesthetised and conscious dogs.
Einstein R; Goodman AH; Yeoh EB
J Auton Pharmacol; 1986 Mar; 6(1):9-14. PubMed ID: 3957953
[TBL] [Abstract][Full Text] [Related]
4. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
5. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
Chang DH; Einstein R
J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671
[TBL] [Abstract][Full Text] [Related]
6. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
Hedberg A; Carlsson E; Fellenius E; Lundgren B
Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
[TBL] [Abstract][Full Text] [Related]
7. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic comparison between prenalterol and dobutamine.
Wester HA; Oltmanns D
Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
[TBL] [Abstract][Full Text] [Related]
10. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
11. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
Wirtzfeld A; Klein G; Bibra HV; Sauer E
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
[TBL] [Abstract][Full Text] [Related]
12. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
Williams RS
J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the inotropic: chronotropic selectivity of dobutamine and dopamine in anaethetised dogs and guinea-pig isolated atria.
Lumley P; Broadley KJ; Levy GP
Cardiovasc Res; 1977 Jan; 11(1):17-25. PubMed ID: 12867
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog.
Vatner DE; Lavallee M; Amano J; Finizola A; Homcy CJ; Vatner SF
Circ Res; 1985 Jul; 57(1):55-64. PubMed ID: 2988820
[TBL] [Abstract][Full Text] [Related]
17. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
Rohm N; Wagner J; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
19. Inotropic selectivity of dobutamine enantiomers in the pithed rat.
Ruffolo RR; Messick K
J Pharmacol Exp Ther; 1985 Nov; 235(2):344-8. PubMed ID: 4057075
[TBL] [Abstract][Full Text] [Related]
20. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
Awad SJ; Einstein R; Potter EK; Richardson DP
Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
